'Sal-mok-ji' Triggers Horror Phenomenon.. Surpasses 2 Million Viewers → 21 Consecutive Weeks at No. 1

*This content was translated by AI.

'Sal-mok-ji' continues its unflagging horror phenomenon by securing the box office No. 1 spot for 21 consecutive days.

According to the Korea Film Council's integrated computer network on the 29th, 'Sal-mok-ji' held the top position in the overall box office for a remarkable 21 days from its release on April 8 through April 28.

As a result, 'Sal-mok-ji' is recorded as the 2026 release that maintained the box office No. 1 spot for the longest duration since its opening day, and as the second-longest-running No. 1 film after 'The King and the Man Who Lives.' Dominating the box office for three weeks, or 21 consecutive days, since its release, the film is writing a new record for Korean horror cinema. Achieving significant milestones at an unprecedented pace for a horror film, it is proving its strength as the absolute box office powerhouse of April.

On the 27th, the film surpassed 2 million viewers, far exceeding its break-even point of 800,000, and continues its box office run. This marks the first time a 2026 Korean film has reached 2 million viewers since 'The King and the Man Who Lives.' Additionally, this is the highest box office score for a horror film since the pandemic and the first time a horror film has reached the 2nd million viewer mark in eight years since 'Gonjiam.'

While the horror phenomenon captivating the entire nation appears unlikely to fade even in the fourth week of release, with 1020-generation audiences increasing their theater visits after midterms conclude, 'Sal-mok-ji's' box office dominance, which enjoys full support from the Gen Z generation, is expected to continue for the foreseeable future.

Meanwhile, 'Sal-mok-ji,' a horror film depicting a mysterious figure captured on the 'Sal-mok-ji' road trip and the filming crew encountering something in the dark, deep water of a reservoir while heading there for reshoots, is currently screening to great acclaim in theaters nationwide.

<© STARNEWS. All rights reserved. No reproduction or redistribution allowed.>

*This content was translated by AI.